文献速递胸部肿瘤放疗放疗物理与技术

非小细胞肺癌根治性胸部再照射适应症与实践的国际专家调查

An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.
PubMed 文献 · Adv Radiat Oncol · 2021-01-20

PURPOSE: Thoracic reirradiation for non-small cell lung cancer with curative intent is potentially associated with severe toxicity. There are limited prospective data on the best method to deliver this treatment.…

要点

  • 合适再照射患者应体能状态良好,可局部复发或第二原发癌,无绝对肺功能值禁忌。
  • 疑似局部复发应行完整诊断检查,再照射应采用最优图像引导和高适形技术。
  • 共识描述了胸部危及器官的累积剂量约束。

核心结论

  • 共识声明为再照射的患者选择、放疗技术和累积剂量约束提供了实践指导。

关键数值与推荐

  • 合适患者应体能状态良好,可局部复发或第二原发癌,无绝对肺功能值禁忌再照射。
  • 疑似局部复发应行完整诊断检查。
  • 再照射应采用最优图像引导和高适形技术。
  • 共识描述了胸部危及器官的累积剂量约束。

临床怎么用

  • 可依据共识选择体能状态良好、局部复发或第二原发癌患者进行再照射。
  • 再照射前应完善诊断检查,治疗中采用图像引导和高适形技术。
  • 可参考共识累积剂量约束保护胸部危及器官。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Thoracic reirradiation for non-small cell lung cancer with curative intent is potentially associated with severe toxicity. There are limited prospective data on the best method to deliver this treatment. We sought to develop expert consensus guidance on the safe practice of treating non-small cell lung cancer with radiation therapy in the setting of prior thoracic irradiation. METHODS AND MATERIALS: Twenty-one thoracic radiation oncologists were invited to participate in an international Delphi consensus process. Guideline statements were developed and refined during 4 rounds on the definition of reirradiation, selection of appropriate patients, pretreatment assessments, planning of radiation therapy, and cumulative dose constraints. Consensus was achieved once ≥75% of respondents agreed with a statement. Statements that did not reach consensus in the initial survey rounds were revised based on respondents' comments and re-presented in subsequent rounds. RESULTS: Fifteen radiation oncologists participated in the 4 surveys between September 2019 and March 2020. The first 3 rounds had a 100% response rate, and the final round was completed by 93% of participants. Thirty-three out of 77 statements across all rounds achieved consensus. Key recommendations are as follows: (1) appropriate patients should have a good performance status and can have locally relapsed disease or second primary cancers, and there are no absolute lung function values that preclude reirradiation; (2) a full diagnostic workup should be performed in patients with suspected local recurrence and; (3) any reirradiation should be delivered using optimal image guidance and highly conformal techniques. In addition, consensus cumulative dose for the organs at risk in the thorax are described. CONCLUSIONS: These consensus statements provide practical guidance on appropriate patient selection for reirradiation, appropriate radiation therapy techniques, and cumulative dose constraints.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Rulach R, Ball D, Chua KLM, et al. An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer. Adv Radiat Oncol. 2021. PMID: 33851065. doi:10.1016/j.adro.2021.100653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。